Texas Administrative Code
Title 25 - HEALTH SERVICES
Part 1 - DEPARTMENT OF STATE HEALTH SERVICES
Chapter 1 - MISCELLANEOUS PROVISIONS
Subchapter D - LOW-THC CANNABIS FOR COMPASSIONATE USE
Section 1.65 - Compassionate-Use Research and Reporting
Current through Reg. 49, No. 38; September 20, 2024
(a) One or more compassionate-use institutional review boards (CIRBs) may be established to evaluate and approve proposed research to study the medical use of low-THC cannabis, in accordance with Texas Health and Safety Code § 487.253.
(b) When seeking approval from a CIRB, the principal investigator of a proposed research program must clearly identify the medical condition for which a patient will be treated with low-THC cannabis.
(c) A principal investigator shall only study the use of low-THC cannabis in treating the medical condition identified in the proposed research program application approved by a CIRB.
(d) The CIRB shall specify an end date to any study it approves. A study may terminate earlier than the date specified by the CIRB if the principal investigator chooses to end the study early. However, a CIRB shall have authority to suspend or terminate approval of research that is not being conducted in accordance with the CIRB's requirements or that has been associated with unexpected serious harm to subjects.
(e) Approval of a research program by a CIRB is not transferable to another research program.
(f) A medical condition may be treated with low-THC cannabis as part of an approved research program if:
(g) Reports.